Antimicrobial resistance not only undermines the efficacy of current treatments but also endangers the entirety of modern ...

South African healthcare leaders are outpacing their global counterparts when it comes to adopting artificial intelligence, ...

Current treatment for bedaquiline-resistant tuberculosis is linked with poor microbiological responses, unfavorable clinical ...

A five-item tool using spirometry and basic clinical data may predict recurrent tuberculosis with moderate accuracy, helping ...

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile ...

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with potential to replace this current cornerstone in ...

By targeting a previously unexploited metabolic pathway essential for bacterial survival, the drug candidate may offer the potential to develop safer, shorter and more effective treatment regimens ...

Thorough screening for latent TB, hepatitis B, and hepatitis C before b/tsDMARD therapy in RA patients improves safety and ...

The Tulane team has developed a handful of other assays for TB detection, including a mass spec test for paucibacillary TB ...

Early enrolment completion in the global M72 Phase 3 TB vaccine trial marks a significant milestone, with Durban sites contributing to the fight against one of the world's deadliest diseases ...